{{Rsnum
|rsid=10483774
|Gene=ESR2
|Chromosome=14
|position=64296881
|Orientation=plus
|GMAF=0.04591
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ESR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 1.5 | 22.6 | 75.9
| JPT | 0.9 | 15.0 | 84.1
| YRI | 0.0 | 8.2 | 91.8
| ASW | 0.0 | 5.3 | 94.7
| CHB | 1.5 | 22.6 | 75.9
| CHD | 0.0 | 22.2 | 77.8
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 2.8 | 97.2
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.0 | 3.9 | 96.1
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|desc=ESTROGEN RECEPTOR 2; ESR2
|id=601663
|rsnum=10483774
}}

{{PMID|17579196}} Risk factors for hypospadias in the estrogen receptor 2 gene.

{{PMID|19337586|OA=1
}} Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}